Table 2 General demographic and clinical characteristics of patients
Sample size | FCV-19S score | p value | |
|---|---|---|---|
Age groups | |||
Under 50 years old | 139 | 22.27 ± 8.09 | 0.316 |
50–65 years old | 216 | 22.35 ± 8.34 | |
Above 65 years old | 131 | 23.78 ± 9.47 | |
Gender | |||
Male | 162 | 21.71 ± 9.22 | 0.085 |
Female | 324 | 23.21 ± 23.21 | |
Tumor type | |||
Breast | 215 | 23.45 ± 8.23 | 0.435 |
Lung | 33 | 21.48 ± 9.92 | |
Gastrointestinal system | 113 | 22.37 ± 8.76 | |
Urogenital system | 73 | 22.73 ± 8.35 | |
Head–neck | 19 | 19.74 ± 8.83 | |
Other | 33 | 21.97 ± 9.36 | |
Disease stage | |||
Early | 273 | 23.61 ± 8.3 | 0.278 |
Local advanced | 49 | 22.63 ± 7.75 | |
Metastatic | 164 | 21.24 ± 9.14 | |
Control patient | |||
No | 368 | 22.55 ± 8.66 | 0.448 |
Yes | 118 | 23.21 ± 8.41 | |
Does he/she take active cytotoxic KT? | |||
No | 340 | 22.85 ± 8.59 | 0.617 |
Yes | 146 | 22.38 ± 8.63 | |